CROWN BIOSCIENCE, INC.

Crown Bioscience, Inc. specializes in preclinical oncology research services, with a focused expertise in the development and characterization of liver tumor models for therapeutic evaluation. The company leverages advanced in vivo and in vitro platforms to support drug discovery and translational research, delivering high-fidelity disease models that replicate human tumor biology. Their technical capabilities include xenograft and patient-derived xenograft (PDX) model establishment, pharmacodynamic biomarker analysis, and longitudinal tumor response monitoring using standardized oncology endpoints. Crown Bioscience differentiates itself through precision model selection, robust data integrity protocols, and a strong emphasis on reproducibility in preclinical studies critical to regulatory submissions. The contractor has demonstrated direct engagement with the Department of Veterans Affairs, providing specialized laboratory services centered on liver tumor model research. This relationship suggests alignment with VA’s mission to advance veteran-relevant cancer therapeutics through evidence-based preclinical innovation. The work performed is likely supporting internal research initiatives or collaborative programs aimed at improving outcomes for veterans affected by hepatocellular carcinoma and other liver malignancies. Crown Bioscience operates primarily within the Testing Laboratories and Services NAICS category (541380), indicating a service-based model focused on outsourced biomedical research support. Their market positioning is that of a niche preclinical CRO serving government and pharmaceutical clients requiring high-quality, biologically relevant cancer models. While their award history reflects a single recent contract, the specificity of the work indicates a targeted focus on oncology translational research rather than broad-spectrum laboratory testing. As a small business structured as a 2L entity based in San Diego, California, Crown Bioscience maintains a focused operational footprint with no disclosed government certifications. Their geographic location places them within a major biotech corridor, enhancing access to academic and industry collaborators in life sciences. The company’s government market presence is emerging, anchored by specialized, mission-aligned research services for federal health agencies.